D Evrard1, E Routier2, C Mateus2, G Tomasic3, J Lombroso4, F Kolb5, C Robert2, A Moya-Plana6. 1. Head and Neck Surgery Department, Gustave Roussy Cancer Campus, Paris Sud University, Villejuif, France. evrard.diane@gmail.com. 2. Onco-dermatology Department, Gustave Roussy Cancer Campus, Paris Sud University, Saclay University, Villejuif, France. 3. Pathology Department, Gustave Roussy Cancer Campus, Paris Sud University, Villejuif, France. 4. Nuclear Medicine Department, Gustave Roussy Cancer Campus, Paris Sud University, Villejuif, France. 5. Plastic and Reconstructive Surgery Department, Gustave Roussy Cancer Campus, Paris Sud University, Villejuif, France. 6. Head and Neck Surgery Department, Gustave Roussy Cancer Campus, Paris Sud University, Villejuif, France.
Abstract
PURPOSE: Sentinel lymph node biopsy (SLNB) is now a standard of care for cutaneous melanoma, but it is still controversial for cutaneous head and neck melanoma (CHNM). This study aims to confirm the feasibility, accuracy and low morbidity of SLNB in CHNM and evaluate its prognostic value. METHODS: A monocentric and retrospective study on patients with CHNM treated in our tertiary care center (Gustave Roussy) between January 2008 and December 2012 was performed. The feasibility, morbidity and prognostic value of this technique were analysed. RESULTS: One hundred and twenty-four consecutive patients were included. SLNB was realized in 97.6% of the cases. No significant post-operative morbidity was observed. Nineteen percents of patients had a positive SN while only 14.3% of complete lymph node dissections (CLND) had additional nodal metastasis. The risk of recurrence after positive SN was significantly higher (69.2 vs 30.8%, p = 0.043). The false omission rate was low with 7.1%. Overall survival and disease-free survival were better in the negative SN group (82 vs 49%, p < 0.001 and 69.3 vs 41.8%, p = 0.0131). The risk of recurrence was significantly higher in the positive SN group (p = 0.043) and when primary tumour was ulcerated (p = 0.031). Only the mitotic rate of the primary tumour was associated with SN positivity (p = 0.049). CONCLUSION: As in other sites, SLNB status is a strong prognostic factor with comparable false omission rate and no superior morbidity.
PURPOSE: Sentinel lymph node biopsy (SLNB) is now a standard of care for cutaneous melanoma, but it is still controversial for cutaneous head and neck melanoma (CHNM). This study aims to confirm the feasibility, accuracy and low morbidity of SLNB in CHNM and evaluate its prognostic value. METHODS: A monocentric and retrospective study on patients with CHNM treated in our tertiary care center (Gustave Roussy) between January 2008 and December 2012 was performed. The feasibility, morbidity and prognostic value of this technique were analysed. RESULTS: One hundred and twenty-four consecutive patients were included. SLNB was realized in 97.6% of the cases. No significant post-operative morbidity was observed. Nineteen percents of patients had a positive SN while only 14.3% of complete lymph node dissections (CLND) had additional nodal metastasis. The risk of recurrence after positive SN was significantly higher (69.2 vs 30.8%, p = 0.043). The false omission rate was low with 7.1%. Overall survival and disease-free survival were better in the negative SN group (82 vs 49%, p < 0.001 and 69.3 vs 41.8%, p = 0.0131). The risk of recurrence was significantly higher in the positive SN group (p = 0.043) and when primary tumour was ulcerated (p = 0.031). Only the mitotic rate of the primary tumour was associated with SN positivity (p = 0.049). CONCLUSION: As in other sites, SLNB status is a strong prognostic factor with comparable false omission rate and no superior morbidity.
Entities:
Keywords:
Cutaneous melanoma; Head and neck; Micrometastasis; Sentinel node biopsy
Authors: Alistair J Cochran; Rong-Rong Huang; Jonathan Lee; Eijun Itakura; Stanley P L Leong; Richard Essner Journal: Nat Rev Immunol Date: 2006-09 Impact factor: 53.106
Authors: L Jansen; H S Koops; O E Nieweg; M H Doting; B A Kapteijn; A J Balm; A Vermey; J T Plukker; C A Hoefnagel; D A Piers; B B Kroon Journal: Head Neck Date: 2000-01 Impact factor: 3.147
Authors: K E Wells; D P Rapaport; C W Cruse; W Payne; J Albertini; C Berman; G H Lyman; D S Reintgen Journal: Plast Reconstr Surg Date: 1997-09 Impact factor: 4.730
Authors: Stanley P L Leong; Neil A Accortt; Richard Essner; Merrick Ross; Jeffrey E Gershenwald; Barbara Pockaj; Harald J Hoekstra; Carlos Garberoglio; Richard L White; David Chu; Merrill Biel; Kim Charney; Harold Wanebo; Eli Avisar; John Vetto; Seng-Jaw Soong Journal: Arch Otolaryngol Head Neck Surg Date: 2006-04
Authors: Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harold J Hoekstra; Constantine P Karakousis; Christopher A Puleo; Brendon J Coventry; Mohammed Kashani-Sabet; B Mark Smithers; Eberhard Paul; William G Kraybill; J Gregory McKinnon; He-Jing Wang; Robert Elashoff; Mark B Faries Journal: N Engl J Med Date: 2014-02-13 Impact factor: 91.245
Authors: Anthony H Kaveh; Nicole M Seminara; Melynda A Barnes; Aaron J Berger; Frank W Chen; Mike Yao; Denise Johnson; Sean Parsa; Andrew Quon; Susan M Swetter; John B Sunwoo Journal: Head Neck Date: 2015-07-14 Impact factor: 3.147
Authors: Celia Chao; Robert C G Martin; Merrick I Ross; Douglas S Reintgen; Michael J Edwards; R Dirk Noyes; Lee J Hagendoorn; Arnold J Stromberg; Kelly M McMasters Journal: Ann Surg Oncol Date: 2004-03 Impact factor: 5.344
Authors: Kirsten M Baecher; Michael K Turgeon; Caroline R Medin; Geetha Mahendran; Terrill M Flakes; Keith A Delman; Michael C Lowe Journal: Am Surg Date: 2021-11-11 Impact factor: 0.688
Authors: Steffen Spoerl; Gerrit Spanier; Elena Reiter; Michael Gerken; Sebastian Haferkamp; Jirka Grosse; Konstantin Drexler; Tobias Ettl; Monika Klinkhammer-Schalke; René Fischer; Silvia Spoerl; Torsten E Reichert; Christoph Klingelhöffer Journal: Head Face Med Date: 2021-10-22 Impact factor: 2.246
Authors: John E Hanks; Kevin J Kovatch; S Ahmed Ali; Emily Roberts; Alison B Durham; Joshua D Smith; Carol R Bradford; Kelly M Malloy; Philip S Boonstra; Christopher D Lao; Scott A McLean Journal: Otolaryngol Head Neck Surg Date: 2020-02-11 Impact factor: 3.497